MTOR and nonpapillary renal cell carcinoma: In light of these details, and the well supported role of AKT/mTOR in regard to EMT in ccRCC [57], increased scrutiny of Jade-1 as a tumor suppressor of ccRCC and a potential agent inhibiting the EMT phenotype is much needed.